ArticleJSES international2026
Risk factors for postoperative anemia and blood transfusion in primary anatomic and reverse total shoulder arthroplasty.
Article in JSES international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Preoperative Hemoglobin Discriminates Perioperative Transfusion in Reverse Shoulder Arthroplasty: A Single-Center Preliminary Study with Internal Validation and a Candidate Blood-Preparation Threshold.Medicina (Kaunas, Lithuania) · 2026Article
- Blood Transfusion Risk Following Early Versus Delayed Surgery in Hip Fracture Patients on Direct Oral Anticoagulants: A Study Protocol for a Natural Experiment.Journal of clinical medicine · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: With the rise in outpatient shoulder arthroplasty, identifying patients at risk for postoperative blood transfusion is crucial. This study aims to identify risk factors for postoperative anemia and transfusion in primary shoulder arthroplasty. Methods: A retrospective review of 3,253 primary arthroplasties (2,757 patients) who underwent reverse total shoulder arthroplasty (rTSA) and anatomic total shoulder arthroplasty from 2012 to 2022 was conducted. Revision arthroplasty, fracture-related arthroplasty, and hemiarthroplasty were excluded. Postoperative anemia was defined as hemoglobin (Hb) < 8 g/dL on postoperative day 0-1; postoperative transfusion was defined as receiving a transfusion prior to discharge. Binary logistic regression identified significant risk factors for postoperative anemia or blood transfusion. Results: Of 3,253 shoulder arthroplasties, 72.4% were rTSA and 27.6% were anatomic total shoulder arthroplasty. The overall rate of postoperative anemia was 0.01%, and the postoperative transfusion rate was 16.3%. Major risk factors for postoperative anemia included female sex (odds ratio [OR] 2.57; Conclusion: Female sex, American Society of Anesthesiologists score > 2, and abnormal preoperative Hb are major risk factors associated with postoperative anemia, while preoperative anticoagulant use and lack of TXA are major risk factors for transfusion. TXA infusion displays a protective effect against transfusion but not postoperative anemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.